The global respiratory inhaler devices industry is poised for exceptional growth, marking a significant valuation of US$ 37,258.5 million in 2023 and projected to escalate to an impressive US$ 60,114.7 million by 2033. This substantial expansion forecasts a Compound Annual Growth Rate (CAGR) of 4.90% during the forecast period. The rising prevalence of respiratory diseases, …